Lenvatinib
Product Description
| Catalogue Number | L329400 |
| Chemical Name | Lenvatinib |
| Synonyms | 4-[3-Chloro-4-[[(cyclopropylamino)carbonyl]amino]phenoxy]-7-methoxy-6-quinolinecarboxamide;4-[3-Chloro-4-[(cyclopropylaminocarbonyl)amino]phenoxy]-7-methoxy-6-quinolinecarboxamide; E 7080; ER 203492-00 |
| CAS Number | 417716-92-8 |
| Molecular Formula | C₂₁H₁₉ClN₄O₄ |
| Appearance | White to Beige Solid |
| Melting Point | >216C (dec.) |
| Molecular Weight | 426.85 |
| Storage | 4°C |
| Solubility | DMSO (Slightly), Methanol (Slightly, Heated) |
| Category | Research Tools; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites; |
| Applications | Lenvatinib is an orally active inhibitor of multiple receptor tyrosine kinases including VEGF, FGF and SCF receptors. |
| References | Matsui, J., et al.: Clin. Cancer Res., 14, 5459 (2008); Gild, M., et al.: Nature Rev. Endocrinol., 7, 617 (2011) |
